About us

Bioceros B.V. is a privately owned company. It was founded in April 2003 as a biopharmaceutical R&D contract organization. Each founding member of the enthusiastic team has more than 15 years of experience in biotech industry. The Company has state-of-the-art facilities in Utrecht, The Netherlands.

Mission statement

Bioceros´ mission is to become a leading biotech company in the development of anti-inflammatory and anti-cancer biopharmaceutical drugs. Bioceros has a dual strategy as it uses it´s technology platform for:

• offering services to the industry and academia, which make Bioceros financially profitable
• exploits its in-house technology platform for pre-clinical development of in-licensed proprietary molecules or for co-development of early stage products in the field of allergy, auto-immunity, inflammation and cancer.

We are interested in in-licensing opportunities. Please contact us if you think the Bioceros technology and expertise can add value to your program.

Strategy

Our short-term strategy is to expand existing Bioceros technology platform and to spread out our cell line generation and process development activities. Simultaneously we will use our technology platform for pre-clinical development of in-licensed proprietary molecules or co-development of early stage anti-inflammation and anti-cancer products. The long-term goal is to obtain clinical proof of concept of lead candidate.